• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对新冠肺炎推荐的精选阿育吠陀配方的化学特征分析。

Chemical profiling of selected Ayurveda formulations recommended for COVID-19.

作者信息

C T Sulaiman, M Deepak, P R Ramesh, K Mahesh, E M Anandan, Balachandran Indira

机构信息

Phytochemistry Division, Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, Malappuram, Kerala 676503 India.

Clinical Research Department, Arya Vaidya Sala, Kottakkal, Kerala India.

出版信息

Beni Suef Univ J Basic Appl Sci. 2021;10(1):2. doi: 10.1186/s43088-020-00089-1. Epub 2021 Jan 11.

DOI:10.1186/s43088-020-00089-1
PMID:33457430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7799399/
Abstract

BACKGROUND

The novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is the global health concern since December 2019. It has become a big challenge for the researchers to find a solution for this newly evolved pandemic. In Ayurveda point of view, COVID-19 is a (epidemic disease), a situation where the environment-air, water, land, and seasons-is vitiated, causing a simultaneous manifestation of a disease among large populations. The aim of this study is to identify the active compounds of selected Ayurveda medicines recommended for COVID-19.

RESULTS

The selected preparations are traditionally recommended for the management of various kinds of fever including the infectious ones and to enhance the immunity. HPTLC analysis of the same showed presence of many active molecules like umbelliferone, scopoletin, caffeic acid, ferulic acid, gallic acid, piperine, curcumin, berberine, and palmatine.

CONCLUSION

The study provided valuable scientific data regarding the active ingredients of the selected medicines with proven therapeutic potentials like anti-viral, immunomodulatory, and anti-inflammatory activities.

摘要

背景

2019年新型冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,自2019年12月以来一直是全球关注的健康问题。对于研究人员来说,找到解决这种新出现的大流行病的方法已成为一项巨大挑战。从阿育吠陀的角度来看,COVID-19是一种(流行病),即环境——空气、水、土地和季节——受到污染,导致大量人群同时出现疾病的情况。本研究的目的是确定推荐用于COVID-19的选定阿育吠陀药物的活性成分。

结果

所选制剂传统上推荐用于治疗包括感染性发热在内的各种发热,并增强免疫力。对其进行的高效薄层色谱分析表明存在许多活性分子,如伞形花内酯、东莨菪素、咖啡酸、阿魏酸、没食子酸、胡椒碱、姜黄素、小檗碱和巴马汀。

结论

该研究提供了有关所选药物活性成分的宝贵科学数据,这些成分具有抗病毒、免疫调节和抗炎等已证实的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5a/7799399/981c62a682d9/43088_2020_89_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5a/7799399/981c62a682d9/43088_2020_89_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5a/7799399/981c62a682d9/43088_2020_89_Fig1_HTML.jpg

相似文献

1
Chemical profiling of selected Ayurveda formulations recommended for COVID-19.针对新冠肺炎推荐的精选阿育吠陀配方的化学特征分析。
Beni Suef Univ J Basic Appl Sci. 2021;10(1):2. doi: 10.1186/s43088-020-00089-1. Epub 2021 Jan 11.
2
Management of w.s.r to COVID-19 - Case report.新型冠状病毒肺炎相关白塞病的管理——病例报告
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100416. doi: 10.1016/j.jaim.2021.02.007. Epub 2021 Mar 6.
3
Ayurvedic treatment of COVID-19: A case report.阿育吠陀疗法治疗新冠肺炎:一例病例报告。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100329. doi: 10.1016/j.jaim.2020.06.001. Epub 2020 Jun 19.
4
An Insight of Clinical Evidence of Ayurveda Interventions in the Management of COVID-19 Patients.阿育吠陀干预措施在 COVID-19 患者管理中的临床证据洞察。
Infect Disord Drug Targets. 2022;22(6):e210322202491. doi: 10.2174/1871526522666220321152504.
5
A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study.小分子化合物黄连素作为一种口服有效的 COVID-19 和 SARS 治疗候选药物:一项计算和机制研究。
FASEB J. 2021 Apr;35(4):e21360. doi: 10.1096/fj.202001792R.
6
Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory viral illnesses: Phytochemical & pharmacological perspective.在 COVID-19 和类似呼吸道病毒疾病中的顺势疗法草药汤剂的治疗和姑息作用:植物化学和药理学观点。
J Ethnopharmacol. 2022 Oct 28;297:115526. doi: 10.1016/j.jep.2022.115526. Epub 2022 Jul 14.
7
Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.纳米载体中含有的抗病毒精油:预防 COVID-19 和未来传染性大流行的策略。
Pharm Nanotechnol. 2020;8(6):437-451. doi: 10.2174/2211738508666201016151850.
8
Ayurveda and Allopathic Therapeutic Strategies in Coronavirus Pandemic Treatment 2020.2020年冠状病毒大流行治疗中的阿育吠陀医学与对抗疗法治疗策略
Curr Pharmacol Rep. 2020;6(6):354-363. doi: 10.1007/s40495-020-00245-2. Epub 2020 Oct 22.
9
Role of Ayurveda and Yoga-Based lifestyle in the COVID-19 pandemic - A narrative review.阿育吠陀和基于瑜伽的生活方式在COVID-19大流行中的作用——一篇叙述性综述。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100493. doi: 10.1016/j.jaim.2021.07.009. Epub 2021 Jul 19.
10
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.

引用本文的文献

1
Safety and efficacy of COROPROTECT kit as an add-on therapy in the management of mild-to-moderate COVID-19: A randomized, placebo-controlled trial.COROPROTECT试剂盒作为轻至中度新冠肺炎附加治疗的安全性和有效性:一项随机、安慰剂对照试验。
Ayu. 2023 Jan-Mar;44(1):9-16. doi: 10.4103/ayu.ayu_92_22. Epub 2024 Feb 21.
2
A Brief Review on Medicinal Plants-At-Arms against COVID-19.药用植物对抗新冠病毒的简要综述
Interdiscip Perspect Infect Dis. 2023 Apr 24;2023:7598307. doi: 10.1155/2023/7598307. eCollection 2023.

本文引用的文献

1
Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL targeting repurposed drug candidates.SARS-CoV2 的地理多样性演变和针对复制酶 3CL 的计算机分析,以寻找可再利用药物的候选物。
J Transl Med. 2020 Jul 9;18(1):278. doi: 10.1186/s12967-020-02448-z.
2
COVID-19 pandemic: A pragmatic plan for ayurveda intervention.新冠疫情:阿育吠陀干预的务实计划
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100312. doi: 10.1016/j.jaim.2020.04.002. Epub 2020 Apr 23.
3
COVID-19: A promising cure for the global panic.
COVID-19:全球恐慌的有希望的治愈方法。
Sci Total Environ. 2020 Jul 10;725:138277. doi: 10.1016/j.scitotenv.2020.138277. Epub 2020 Apr 4.
4
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.九名孕妇感染 COVID-19 的临床特征和宫内垂直传播潜力:病历回顾性研究。
Lancet. 2020 Mar 7;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. Epub 2020 Feb 12.
5
Coumarin: An emerging antiviral agent.香豆素:一种新兴的抗病毒药物。
Heliyon. 2020 Jan 27;6(1):e03217. doi: 10.1016/j.heliyon.2020.e03217. eCollection 2020 Jan.
6
Induction of functional erythropoietin and erythropoietin receptor gene expression by gamma-aminobutyric acid and piperine in kidney epithelial cells.γ-氨基丁酸和胡椒碱诱导肾上皮细胞功能性促红细胞生成素和促红细胞生成素受体基因表达。
Life Sci. 2018 Dec 15;215:207-215. doi: 10.1016/j.lfs.2018.11.024. Epub 2018 Nov 12.
7
Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders.小檗碱:植物来源、传统用途、提取方法及其在心血管、代谢、肝脏和肾脏疾病中的相关性
Front Pharmacol. 2018 Aug 21;9:557. doi: 10.3389/fphar.2018.00557. eCollection 2018.
8
Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding.姜黄素通过抑制细胞结合来抑制寨卡病毒和基孔肯雅病毒感染。
Antiviral Res. 2017 Jun;142:148-157. doi: 10.1016/j.antiviral.2017.03.014. Epub 2017 Mar 24.
9
Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model.黄连素对大鼠实验性自身免疫性心肌炎的保护机制
Biomed Pharmacother. 2016 Apr;79:222-30. doi: 10.1016/j.biopha.2016.02.015. Epub 2016 Mar 11.
10
Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.一些香豆素和苯并恶嗪酮作为有效的对氧磷酶1抑制剂。
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1386-91. doi: 10.3109/14756366.2016.1142982. Epub 2016 Feb 17.